AAAAAA

   
Results: 1-15 |
Results: 15
Differential DM20 mRNA expression distinguishes two distinct patterns of spontaneous recovery from murine autoimmune encephalomyelitis
Authors: Mathisen, PM Kawczak, JA Yu, M Johnson, JM Tuohy, VK
Citation: Pm. Mathisen et al., Differential DM20 mRNA expression distinguishes two distinct patterns of spontaneous recovery from murine autoimmune encephalomyelitis, J NEUROSC R, 64(5), 2001, pp. 542-551
Pre-emptive targeting of the epitope spreading cascade with genetically modified regulatory T cells during autoimmune demyelinating disease
Authors: Yin, L Yu, M Edling, AE Kawczak, JA Mathisen, PM Nanavati, T Johnson, JM Tuohy, VK
Citation: L. Yin et al., Pre-emptive targeting of the epitope spreading cascade with genetically modified regulatory T cells during autoimmune demyelinating disease, J IMMUNOL, 167(11), 2001, pp. 6105-6112
Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells
Authors: Klein, L Klugmann, M Nave, KA Tuohy, VK Kyewski, B
Citation: L. Klein et al., Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells, NAT MED, 6(1), 2000, pp. 56-61
Gene therapy in experimental autoimmune encephalomyelitis
Authors: Mathisen, PM Tuohy, VK
Citation: Pm. Mathisen et Vk. Tuohy, Gene therapy in experimental autoimmune encephalomyelitis, J CLIN IMM, 20(5), 2000, pp. 327-333
Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibitsthe development of epitope spreading and disease progression in murine autoimmune encephalomyelitis
Authors: Tuohy, VK Yu, M Yin, L Mathisen, PM Johnson, JM Kawczak, JA
Citation: Vk. Tuohy et al., Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibitsthe development of epitope spreading and disease progression in murine autoimmune encephalomyelitis, J NEUROIMM, 111(1-2), 2000, pp. 55-63
The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents
Authors: Dinter, H Tse, J Halks-Miller, M Asarnow, D Onuffer, J Faulds, D Mitrovic, B Kirsch, G Laurent, H Esperling, P Seidelmann, D Ottow, E Schneider, H Tuohy, VK Wachtel, H Perez, HD
Citation: H. Dinter et al., The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents, J NEUROIMM, 108(1-2), 2000, pp. 136-146
T cell design for therapy in autoimmune demyelinating disease
Authors: Tuohy, VK Mathisen, PM
Citation: Vk. Tuohy et Pm. Mathisen, T cell design for therapy in autoimmune demyelinating disease, J NEUROIMM, 107(2), 2000, pp. 226-232
Alterations in cardiac function and gene expression during autoimmune myocarditis in mice
Authors: Stull, LB DiIulio, NA Yu, M McTiernan, CF Ratliff, NB Tuohy, VK Moravec, CS
Citation: Lb. Stull et al., Alterations in cardiac function and gene expression during autoimmune myocarditis in mice, J MOL CEL C, 32(11), 2000, pp. 2035-2049
Regression and spreading of self-recognition during the development of autoimmune demyelinating disease
Authors: Tuohy, VK Yu, M Yin, L Kawczak, JA Kinkel, RP
Citation: Vk. Tuohy et al., Regression and spreading of self-recognition during the development of autoimmune demyelinating disease, J AUTOIMMUN, 13(1), 1999, pp. 11-20
Th2 T cells expressing transgene PDGF-A serve as vectors for gene therapy in autoimmune demyelinating disease
Authors: Mathisen, PM Yu, M Yin, L Johnson, JM Kawczak, JA Nishiyama, A Tuohy, VK
Citation: Pm. Mathisen et al., Th2 T cells expressing transgene PDGF-A serve as vectors for gene therapy in autoimmune demyelinating disease, J AUTOIMMUN, 13(1), 1999, pp. 31-38
Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors
Authors: Folcik, VA Smith, T O'Bryant, S Kawczak, JA Zhu, B Sakurai, H Kajiwara, A Staddon, JM Glabinski, A Chernosky, AL Tani, M Johnson, JM Tuohy, VK Rubin, LL Ransohoff, RM
Citation: Va. Folcik et al., Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors, J NEUROIMM, 97(1-2), 1999, pp. 119-128
Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis
Authors: Tuohy, VK Yu, M Yin, L Kawczak, JA Kinkel, RP
Citation: Vk. Tuohy et al., Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis, J EXP MED, 189(7), 1999, pp. 1033-1042
Visinin-like protein (VILIP) is a neuron-specific calcium-dependent double-stranded RNA-binding protein
Authors: Mathisen, PM Johnson, JM Kawczak, JA Tuohy, VK
Citation: Pm. Mathisen et al., Visinin-like protein (VILIP) is a neuron-specific calcium-dependent double-stranded RNA-binding protein, J BIOL CHEM, 274(44), 1999, pp. 31571-31576
T-cell design: optimizing the therapeutic potential of autoreactive T cells by genetic modification
Authors: Tuohy, VK Mathisen, PM
Citation: Vk. Tuohy et Pm. Mathisen, T-cell design: optimizing the therapeutic potential of autoreactive T cells by genetic modification, RES IMMUNOL, 149(9), 1998, pp. 834-842
Immunoregulation of experimental autoimmune encephalomyelitis - 75th Forumin immunology - General comments
Authors: Kuchroo, VJ Weiner, HL Tuohy, VK Hjelmstrom, P Juedes, A Ruddle, NH
Citation: Vj. Kuchroo et al., Immunoregulation of experimental autoimmune encephalomyelitis - 75th Forumin immunology - General comments, RES IMMUNOL, 149(9), 1998, pp. 855-858
Risultati: 1-15 |